En Meng

Dr. En Meng


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JCJuin-Hong Cherng
Juin-Hong Cherng
SCSheng-Chieh Chou
Sheng-Chieh Chou
CCChin-Li Chen
Chin-Li Chen
YWYi-Wen Wang
Yi-Wen Wang
SCShu-Jen Chang
Shu-Jen Chang
EMEn Meng
En Meng
Currently, there are several therapeutic approaches available for wound injury management. However, a better understanding of the underlying mechanisms of how biomaterials affect cell behavior is needed to develop potential repair strategies. Bacterial cellulose (BC) is a bacteria-produced biopolymer with several advantageous qualities for skin tissue engineering. The aim here was to investigate BC-based scaffold on epithelial regeneration and wound healing by examining its effects on the expression of scavenger receptor-A (SR-A) and underlying macrophage behavior. Full-thickness skin wounds were generated on Sprague-Dawley rats and the healing of these wounds, with and without BC scaffolds, was examined over 14 days using Masson’s trichome staining. BC scaffolds displayed excellent in vitro biocompatibility, maintained the stemness function of cells and promoted keratinocyte differentiation of cells, which are vital in maintaining and restoring the injured epidermis. BC scaffolds also exhibited positive in vivo effects on the wound microenvironment, including improved skin extracellular matrix deposition and controlled excessive inflammation by reduction of SR-A expression. Furthermore, BC scaffold significantly enhanced epithelialization by stimulating the balance of M1/M2 macrophage re-programming for beneficial tissue repair relative to that of collagen material. These findings suggest that BC-based materials are promising products for skin injury repair.

24 March 2022 in Biology
Verified
Journal Article
Open access
PDF file
CCChin-Li Chen
Chin-Li Chen
SWSheng-Tang Wu
Sheng-Tang Wu
TCTai-Lung Cha
Tai-Lung Cha
GSGuang-Huan Sun
Guang-Huan Sun
EMEn Meng
En Meng
Ketamine was first synthesized as a clinical medicine for anesthesia in 1970. It has been used as a recreational drug because of its low cost and hallucination effect in the past decade. Part of ketamine abusers may experience ketamine-related cystitis (KC) and suffer from lower urinary tract symptoms, including urinary frequency, urgency, and severe bladder pain. As the disease progression, a contracted bladder, petechial hemorrhage of the bladder mucosa, and ureteral stricture with hydronephrosis may occur. The pathophysiology of KC is still uncertain, although several hypotheses have been raised. Cessation of ketamine abuse is critical for the management of KC to prevent progressive disease, and effective treatment has not been established. Research has provided some theoretical bases for developing in vitro experiments, animal models, and clinical trials. This review summarized evidence of molecular mechanisms of KC and potential treatment strategies for KC. Further basic and clinical studies will help us better understand the mechanism and develop an effective treatment for KC.

5 September 2021 in Cancers
Verified
Journal Article
Open access
PDF file
CCChin-Li Chen
Chin-Li Chen
EMEn Meng
En Meng
SWSheng-Tang Wu
Sheng-Tang Wu
HLHsing-Fan Lai
Hsing-Fan Lai
YLYi-Shan Lu
Yi-Shan Lu
YCYi-Lin Chiu
Yi-Lin Chiu
Clinical bladder tumor histological analysis shows that high expression of S1PR1 is associated with poor patient prognosis. However, there are no studies that describe the underlying mechanism. To investigate the relative distribution and actual function of S1PR1 in bladder tumors, we analyzed multiple clinical databases in combination with tumor purity and immune cell infiltration simulations, as well as databases of well-defined histological phenotypes of bladder cancer, and single-cell sequencing of adjacent normal tissues and bladder tumors, and further compared them with bladder cancer cell lines. The results showed that S1PR1 expression was generally higher in normal tissues than in bladder cancer tissues, and its distribution was mainly in endothelial cells or immune cells. The association between high S1PR1 expression and poor prognosis may be due to tumor invasion of adjacent normal tissues, where highly expressed S1PR1 may affect prognostic interpretation. The effect of S1PR1 itself on cancer cells was associated with cell adhesion, and in bladder cancer cells, S1PR1 expression was negatively correlated with cell motility. Moreover, the use of FTY-720 will cause an increased metastatic ability of bladder cancer cells. In conclusion, we suggest that the use of S1PR1-specific inhibition as a synergistic treatment requires more observation and consideration.

21 April 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
PLPo-An Llin
Po-An Llin
HHHSIANG-HAN HUANG
HSIANG-HAN HUANG
MHMei-Hua Hu Hu
Mei-Hua Hu Hu
GHGo-Shine Huang
Go-Shine Huang
EMEn Meng
En Meng
WCWei-Hung Chan
Wei-Hung Chan
Background: This study aimed to investigate the effects of prostate tissue on platelet activation markers, primarily assessed through P-selectin expression, and to assess the formation of platelet–leukocyte aggregations in response to prostate tissue exposure. Furthermore, we compared platelet activation induced by prostate tissue homogenates with that induced by thrombin stimulation. These processes may play a role in the development of disseminated intravascular coagulation (DIC) following transurethral resection of the prostate (TURP). Methods: We collected prostate tissue samples from 12 patients undergoing TURP. The samples were homogenized and used to stimulate platelet-rich plasma in vitro. Flow cytometry was used to measure platelet P-selectin expression and platelet–leukocyte aggregation. Additionally, four experimental groups were established: (A) saline control, (B) thrombin stimulation, (C) phosphate-buffered saline (PBS) control, and (D) prostate tissue homogenate. Data were analyzed to assess the impact of prostate tissue and thrombin on platelet activation and platelet–leukocyte interactions. Results: Prostate tissue homogenates significantly increased platelet P-selectin expression and platelet–neutrophil aggregation compared with the control groups (p < 0.05). Overall, platelet–leukocyte aggregation was not significantly different between the thrombin and prostate tissue groups. However, prostate tissue exposure did not significantly affect platelet–monocyte and platelet–lymphocyte aggregations. Conclusions: Prostate tissue exposure during TURP induces platelet activation, particularly platelet P-selectin expression and platelet–neutrophil aggregation, suggesting a potential mechanism for DIC development. These findings highlight the importance of monitoring platelet activity in patients undergoing TURP and indicate that interventions targeting platelet P-selectin expression and platelet–neutrophil interactions may help mitigate DIC risk.

1 September 2025 in Urology Case Reports
Verified
Journal Article
Open access
PCPin-Yu Chen
Pin-Yu Chen
HTHui-Kung Ting
Hui-Kung Ting
EMEn Meng
En Meng
We report a case of a 74-year-old postmenopausal woman with stage III cystocele and a non-circumferential urethral caruncle presenting with bulge, voiding difficulty, occasional bleeding, and meatal discomfort. She underwent anterior colporrhaphy followed by excision of the urethral caruncle using the LigaSure™ device. The procedure was completed within 1 min, with minimal blood loss and no suturing. Postoperative follow-ups showed good wound healing without recurrence or urethral stricture. This case suggests that LigaSure™ may enable rapid, sutureless excision in selected non-circumferential lesions.